Michelle Yeomans

I joined the Inspectorate in 2005 and have worked across the GXP teams as an Inspector, Senior Inspector and GMDP Operations Manager. In October 2017, I took on a full time project based role focusing on business process improvement and to lead the Inspectorate inputs to the Agency's Operational Transformation Programme and Digital Transformation projects going forward.

Inspector Recruitment – Part Two

Michelle Yeomans, 29 January 2020 - Good clinical practice, Good distribution practice, Good laboratory practice, Good manufacturing practice, Good pharmacovigilance practice, Inside the Inspectorate, Wider MHRA

In part 1 of the inspectorate recruitment posts, we provided information on the inspector role and recruitment process, part 2 provides more information on the benefits and opportunities available to MHRA inspectors.

Inspector Recruitment -Part One

Michelle Yeomans, 17 January 2020 - Good clinical practice, Good distribution practice, Good laboratory practice, Good manufacturing practice, Good pharmacovigilance practice, Inside the Inspectorate, Wider MHRA

Have you ever thought about becoming an MHRA inspector but wanted to know more about the role, the application process, or the benefits associated with joining a talented and dynamic team protecting public health? Part one of this two-part blog will hopefully give you the information you need to consider for applying for future roles.

It pays to be compliant!

Michelle Yeomans, 11 January 2019 - Compliance matters, Good clinical practice, Good distribution practice, Good laboratory practice, Good manufacturing practice, Good pharmacovigilance practice

In a bid to drive improved compliance and to cover the cost of managing more resource-intensive cases, the Inspectorate intends to apply the existing office-based assessment fee more broadly.

Operational Transformation Programme – an Inspectorate view

Michelle Yeomans, 22 March 2018 - Inside the Inspectorate, Wider MHRA

This post provides some background information to the aims of the operational transformation programme and how the inspectorate is rising to the challenge.

2016 GMP symposium

Michelle Yeomans, 24 January 2017 - Compliance matters, Events and symposia, Good manufacturing practice

It was a case of “lights, camera, action!” for the GMP days of the 2016 MHRA Symposium, with speakers making use of video clips, music, and pictures in order to deliver key messages.

Helping us to help you

Michelle Yeomans, 5 January 2017 - Compliance matters, Good distribution practice, Good laboratory practice, Good manufacturing practice, Wider MHRA

6 top tips for applicants submitting a Manufacturing Authorisation application or variation

Transitional QPs for Investigational Medicinal Products (IMPs) - Update

Michelle Yeomans, 29 April 2016 - Compliance matters, Good clinical practice, Good manufacturing practice

We are aware there is some concern for UK business and personal careers, over the status of transitional QPs that were recognised under the transitional arrangements provided in SI 2004/1031, when the Clinical Trials Directive was implemented in 2004. The …

Notification to MS licence holders due to compliance concerns

Michelle Yeomans, 15 April 2016 - Compliance matters, Good manufacturing practice

In January 2015, MHRA published guidance to ‘specials’ manufactures, to provide an interpretation of the good manufacturing practice (GMP) requirements for specials manufacturers. The GMDP Inspectorate have been concerned that some Specials manufacturers have not always been receiving written orders …

GMDP Symposium 2015 – GMP days

Michelle Yeomans, 11 March 2016 - Compliance matters, Events and symposia, Good distribution practice, Good manufacturing practice

Not to be outshone by our GDP colleagues, this post is to communicate the highlights from the GMP days at the 2015 MHRA Symposium. I’m Michelle Rowson, a GMDP Operations Manager, and part of my role is to lead in planning …

Transitional QPs for investigational medicinal products (IMPs)

Michelle Yeomans, 12 February 2016 - Compliance matters, Good clinical practice, Good manufacturing practice

We are aware there is some concern for UK business and personal careers, over the status of transitional QPs that were recognised under the transitional arrangements provided in SI 2004/1031, when the Clinical Trials Directive was implemented in 2004. The …

About the MHRA Inspectorate Blog

This blog shares the work of the Medicines and Healthcare products Regulatory Agency (MHRA) Inspectorate, by inspectors and those the Inspectorate works with.

Find out more

Categories

Follow us on social media

• MHRA Twitter
• MHRA Medicines Twitter
• LinkedIn company page

Sign up and manage updates

• Email
• Atom

Printing Posts

You can print blog posts using the keyboard shortcuts "Control P" or "Command P".

Other MHRA Blogs

MedRegs

Comments and moderation

Read our guidelines

Recent posts

• MHRA Good Clinical and Laboratory Practice Symposia (11 and 12 February 2025)
• Public Consultation on the International Council for Harmonisation ICH E6 (R3) Guideline for Good Clinical Practice Annex-2
• DSUR Submissions and Fees are Changing from 1 June 2024
• Pharmacovigilance unravelled: highlights of the 2024 MHRA GPvP Symposium
• Pilot GMP Single Inspection Program